SCHEMBL18727156

SCHEMBL18727156

CCCc1ccc2nc(C(C)(C)C)[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ SCN10A Q9Y5Y9 3/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ S1PR4 O95977 4/20 0.43
▸ S1PR1 P21453 4/20 0.43
▸ S1PR5 Q9H228 4/20 0.43
▸ TUBB4A P04350 4/20 0.43
▸ TUBB P07437 4/20 0.43
▸ TUBA3C P0DPH7 4/20 0.43
▸ TUBA1B P68363 4/20 0.43
▸ TUBA4A P68366 4/20 0.43
▸ TUBB4B P68371 4/20 0.43
▸ TUBB3 Q13509 4/20 0.43
▸ TUBB2A Q13885 4/20 0.43
▸ TUBB8 Q3ZCM7 4/20 0.43
▸ TUBA3E Q6PEY2 4/20 0.43
▸ TUBA1A Q71U36 4/20 0.43
▸ TUBA1C Q9BQE3 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23776494 0.91 TUBB4A (0.53) ALDH1A1SMN1; SMN2L3MBTL1SCN10AKCNH2
SCHEMBL12231816 0.87 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2L3MBTL1SCN10AKCNH2
SCHEMBL20863743 0.79 TUBB4A (0.41) ALDH1A1SMN1; SMN2L3MBTL1S1PR4S1PR1
SCHEMBL14756346 0.78 TUBB4A (0.45) ALDH1A1S1PR4S1PR1S1PR5TUBB4A
SCHEMBL10707113 0.78 TUBB4A (0.45) ALDH1A1S1PR4S1PR1S1PR5TUBB4A
SCHEMBL5924403 0.78 BACE1 (0.53) ALDH1A1S1PR4S1PR1S1PR5TUBB4A
SCHEMBL22487867 0.76 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2L3MBTL1SCN10AKCNH2
SCHEMBL18922591 0.76 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2L3MBTL1SCN10AKCNH2
SCHEMBL15156602 0.76 SCN10A (0.49) SCN10AKCNH2S1PR4S1PR1S1PR5
SCHEMBL846652 0.75 SCN10A (0.78) ALDH1A1SMN1; SMN2L3MBTL1SCN10AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3153515-A1 COMPOUNDS FOR INHIBITING HEPATITIS C VIRUS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF AB Pharma Ltd (CN) 2017-04-12 — — EP disclosed
Send feedback